Don't forget the 130million options traded on that day for a cheap price. Also another announcement this month to be made in relation to the start of phase III trials. This should create more interest in the stock.
holding 2m options to see what happens. Risk v reward to good at these levels for a phase III stock.
Ann: Phase III Clinical Trial Investor Webinar, page-93
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $2 | 1.126K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 34751789 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40153304 | 27 |
View Market Depth
| Last trade - 12.40pm 08/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |